Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Topical WBI-1001 improves atopic dermatitis in double-blind trial

March 10, 2010

Foamix and Therapeutics collaborate to develop inflammatory skin disease therapies

March 5, 2010

Capstone continues phase II trial of AZX-100 in keloid scarring

March 4, 2010

Renovo and Shire revise licensing deal for Juvista

March 3, 2010

Welichem Biotech begins enrollment in phase IIa WBI-1001 trial in psoriasis

March 2, 2010

Ceragenix and BexPharm enter into agreement for EpiCeram

Feb. 23, 2010

Boehringer Ingelheim claims new chemokine CCR10 receptor antagonists

Feb. 4, 2010

Leo Pharma reports results from phase III study of PEP-005 for treatment of AK lesions

Feb. 2, 2010

Mitsubishi Tanabe's Remicade approved for the additional indication of psoriasis

Jan. 22, 2010

Promising clinical effects with topical miltefosine and clobetasol in cutaneous mastocytosis

Jan. 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...